IRS (Finally) Issues Guidance for the Cannabis Industry

By October 1, 2020 October 2nd, 2020 Cannabis, Tax

The Internal Revenue Service (IRS) recently published an entire webpage on their site dedicated to tax policy for the cannabis industry – particularly marijuana businesses. The site includes information on a number of relevant topics such as section 280E guidance, reporting taxes, making large payments with cash, and more.

Although marijuana remains a banned substance under federal law, thus depriving those in the industry of certain US federal benefits (e.g., tax deductions for business expenses other than cost of goods sold (COGS), bankruptcy, copyright and trademark protections, etc), cannabis companies still have an obligation to pay taxes and properly report transactions. The latest guidance provided by the IRS is designed to “help promote voluntary compliance in the industry.”

So what does the IRS have to say about marijuana companies and taxes?

Overview: What is in the tax guidance?

The new IRS webpage addressing tax concerns for marijuana companies, aims to inform business owners about their tax compliance responsibilities.

The page notes that many cannabis industry businesses conduct transactions in cash, which need to be reported, like any other form of payment. It also provides information about income reporting, cash payment options for unbanked taxpayers, estimated US federal income tax payments, and the importance of robust recordkeeping (i.e., cash sourcing and tracking).

In addition, the webpage includes a number of resources pertaining to the concerns of the cannabis industry. Among these resources are: Frequently Asked Questions (FAQ), information about paying your taxes in cash, and reporting single cash transactions of more than $10,000. In addition, it provides a cash-intensive business audit techniques guide.

[Back to Top]

Is income from the sale of marijuana federally taxable?

While still prohibited by US federal law, today, 33 states and the District of Columbia have laws legalizing marijuana for either medical or recreational use. As of the summer of 2020, the breakdown is as follows:

Legalized Marijuana for Medical Use: Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Hawaii, Illinois, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, Utah, Vermont, Washington, and West Virginia.

Legalized Marijuana for Recreational Use: Alaska, California, Colorado, Illinois, Maine, Michigan, Nevada, Oregon, Vermont, and Washington.

However, regardless of the legality of the product or business operation, for US income tax purposes, income from any source is taxable, including income from the sale of marijuana or marijuana-related products. On the IRS’ new webpage, it points out that federal courts have consistently upheld its determinations that income derived from both state legally-compliant as well non-compliant or illegal marijuana sales are subject to US federal income tax.

[Back to Top]

What does the IRS say about section 280E?

The IRS reminds “businesses that traffic marijuana in contravention of federal or state law” that they are subject to the limitations of Internal Revenue Code (IRC) section 280E. As many in the industry know, section 280E disallows US federal income tax deductions for business operating expenses other than COGS, which results in extraordinarily high US federal effective tax rates and cash tax liabilities that are not in line with the actual economic costs of operations and has severely negatively impacted marijuana-related businesses by .

You can find more information about section 280E and its effects on the cannabis industry here.

[Back to Top]

What is included in the IRS’ marijuana industry FAQ?

As mentioned above, one resource the IRS issued in conjunction with their new webpages is a Marijuana Industry FAQ. On a broad scale, the FAQ addresses federal tax filing and information reporting requirements specific to taxpayers involved with the production, processing, sale or distribution of marijuana products.

It explains how court rulings have clarified that businesses are required to pay US federal income taxes, even if they are selling products considered illegal under state or federal law. It also explains that marijuana companies are eligible for payment plans if they are unable to pay their taxes in full. Further, it states that cannabis operations are subject to the same penalties as any other business during an income tax examination by the IRS.

The FAQ also note that while section 280E disallows all deductions or credits for any amount paid or incurred in carrying on any business that violates federal drug laws (including those that sell marijuana in states that have legalized the sale of marijuana), section 280E does not prohibit a participant in the marijuana industry from reducing their gross receipts by properly calculating their cost of goods sold (COGS) to determine gross income. Generally, this means that taxpayers who sell marijuana may reduce their gross receipts by the cost of acquiring or producing marijuana that they sell, and these costs will depend on the nature of the business. In other words, while cannabis businesses are not eligible for most traditional deductions, they are able to calculate the cost of goods sold and get some tax relief. So, for example, no deductions for advertising, but yes to deducting COGS.

[Back to Top]

What is the general takeaway of the IRS adding these webpages?

Pending a change in the federal status of marijuana (e.g., descheduling as a Tier 1 substance under the CSA), or statutory changes at the agency level, the cannabis industry will continue to be at a disadvantage when it comes to general business and tax allowances – like deducting expenses or even using a bank or credit union to conduct routine financial transactions.

However, the inclusion of tax policy guidance by the IRS, a US federal agency, for marijuana businesses is a positive step toward acknowledging the cannabis industry as one significant enough to warrant establishment of a formal policy on tax collection and reporting, as well as provide some general guidance and answers to taxpayers’ questions which up until now had gone unanswered. The issuance of a dedicated webpage on is a significant signal of not only increased scrutiny but perhaps also of potential developments to reduce taxpayer uncertainty aimed at increased tax compliance.

[Back to Top]

How can Squar Milner help?

Squar Milner has taken pride in being one of the first accounting firms with a dedicated cannabis practice. Situated in California, we have extensive experience working with cannabis companies to develop comprehensive tax strategies and solutions, as well to assist them in overcoming the challenges posed by federal limitations. Our team of experienced professionals can work with you to address any of your needs or concerns, whether you may need tax planning, audit services, structuring and transaction readiness in preparation for potential M&A transactions, or outsourced accounting services to help you manage your cash-intensive business. We understand the unique obstacles present every day in your industry, and we are here to help.

[Back to Top]

Disclaimer: This material has been prepared for informational purposes only, and is not intended to substitute for obtaining accounting, tax, or financial advice from a professional tax planner or financial planner. All information is provided “as is,” with no guarantee of completeness, accuracy, timeliness or of the results obtained from the use of this information.

Our Cannabis Tax, Audit & Consulting Services

Our Cannabis CPAs are able to offer services to all involved in the industry including retailers, cultivators, distributors, cultivation suppliers, equipment, security, waste management, delivery, insurance, cannabis accessories, and hemp products.

Learn More
Manufacturing R&D tax credit
Manufacturing and Distribution

How Manufacturers Can Maximize the R&D Tax Credit

Everyday manufacturing activities often qualify for the advantageous research and development (R&D) tax credit. Companies who test new materials, experiment…

IRS (Finally) Issues Guidance for the Cannabis Industry

The Internal Revenue Service (IRS) recently published an entire webpage on their site dedicated to tax policy for the cannabis…
CBD Market Continues to Grow in 2020

CBD Market Continues to Grow in 2020

At the end of July, the Brightfield Group, a leading consumer insights and marketing intelligence firm, released their 2020 US…